Quick Answer
Harmony Biosciences Holdings, Inc. reported Total Assets of $1.27 billion for the year ending 2025.
- Harmony Biosciences Holdings, Inc. showed an increase of +27.3% in Total Assets from 2024 to 2025.
- This data is from Harmony Biosciences Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $320.07 million | Q1 2021: $337.25 million | Q2 2021: $359.70 million | Q3 2021: $391.09 million | Q1 2022: $464.01 million | Q2 2022: $505.03 million | Q3 2022: $643.46 million | Q1 2023: $715.09 million | Q2 2023: $760.18 million | Q3 2023: $777.77 million | Q1 2024: $846.99 million | Q2 2024: $858.38 million | Q3 2024: $928.14 million | Q1 2025: $1.06 billion | Q2 2025: $1.11 billion | Q3 2025: $1.21 billion.
- Over the full 7 years of available data (2019 to 2025), Harmony Biosciences Holdings, Inc.'s Total Assets has grown by 1,091.7%.
- Historical annual values: Fiscal year 2025: $1.27 billion | Fiscal year 2024: $999.20 million | Fiscal year 2023: $811.45 million | Fiscal year 2022: $673.87 million | Fiscal year 2021: $433.44 million | Fiscal year 2020: $427.07 million | Fiscal year 2019: $106.70 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: